Debt-to-equity of Aquestive Therapeutics, Inc. from 31 Mar 2019 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Aquestive Therapeutics, Inc. quarterly Debt-to-equity in % history and change rate from 31 Mar 2019 to 30 Sep 2025.
  • Aquestive Therapeutics, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was -333%, a 17% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Aquestive Therapeutics, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 -333% -48% -17% 30 Sep 2025
Q2 2025 -270% -41% -18% 30 Jun 2025
Q1 2025 -313% -127% -68% 31 Mar 2025
Q4 2024 -359% -203% -131% 31 Dec 2024
Q3 2024 -285% -132% -86% 30 Sep 2024
Q2 2024 -229% -78% -52% 30 Jun 2024
Q1 2024 -186% -34% -22% 31 Mar 2024
Q4 2023 -155% -2% -1.3% 31 Dec 2023
Q3 2023 -154% +6% +3.8% 30 Sep 2023
Q2 2023 -151% +21% +12% 30 Jun 2023
Q1 2023 -152% +34% +18% 31 Mar 2023
Q4 2022 -153% +50% +25% 31 Dec 2022
Q3 2022 -160% +60% +27% 30 Sep 2022
Q2 2022 -172% +55% +24% 30 Jun 2022
Q1 2022 -187% +64% +26% 31 Mar 2022
Q4 2021 -203% +86% +30% 31 Dec 2021
Q3 2021 -220% +183% +45% 30 Sep 2021
Q2 2021 -227% +181% +44% 30 Jun 2021
Q1 2021 -251% +130% +34% 31 Mar 2021
Q4 2020 -290% +155% +35% 31 Dec 2020
Q3 2020 -403% +158% +28% 30 Sep 2020
Q2 2020 -408% -10812% -104% 30 Jun 2020
Q1 2020 -381% +2198% +85% 31 Mar 2020
Q4 2019 -445% 31 Dec 2019
Q3 2019 -561% 30 Sep 2019
Q2 2019 10403% 30 Jun 2019
Q1 2019 -2580% 31 Mar 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.